Neomycin, Polymyxin, and Bacitracin Topical
Neomycin, polymyxin B, and bacitracin is a triple antibiotic combination used to help prevent infection in minor cuts, scrapes, and burns.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 172 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Neomycin, Polymyxin, and Bacitracin Topical: Patient Information Guide
A plain-language walkthrough of Neomycin, Polymyxin, and Bacitracin Topical — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
This triple antibiotic combination is used across several topical and ophthalmic products to prevent or fight bacterial infection in minor wounds and skin preparation.
- Helps prevent infection in minor cuts, scrapes, and burns (topical cream, ointment, gel, and solution forms)
- Provides temporary relief of pain and itching from minor burns, cuts, scrapes, and insect bites (select topical ointment/cream products)
- Skin preparation before injection — First Aid Antibiotic topical solution; intended for professional and hospital use
- Antiseptic cleansing of the face, hands, and body without soap and water — First Aid Antibiotic topical solution
- Prevention of bacterial eye infections — Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc ophthalmic ointment (applied to the eye)
⚙️How it works▾
Each of the three antibiotics in this combination attacks bacteria differently. Neomycin is an aminoglycoside — it binds to the bacteria's ribosomal RNA (the machinery that reads the genetic code to build proteins), causing it to misread instructions so the bacteria can't make the proteins they need to survive. Polymyxin B targets the outer membrane of gram-negative bacteria, disrupting the phospholipid layer so the membrane leaks and the bacteria die. Bacitracin blocks a step in bacterial cell wall construction, preventing the bacteria from regenerating the building blocks they need to maintain their protective wall.
Together, the three antibiotics cover a broad spectrum — gram-positive bacteria like Staphylococcus aureus and streptococci, and gram-negative bacteria like E. coli, Pseudomonas aeruginosa, and Haemophilus influenzae. Note that this combination does not provide adequate coverage against Serratia marcescens.
💊How it's taken▾
For topical skin products, clean the area first, then apply a small amount — about the size of a fingertip — up to 1 to 3 times daily. You can cover the area with a sterile bandage. Do not apply over large areas of the body or on raw, blistered skin, and do not use for more than one week without a doctor's direction.
- Children under 2 years: consult a doctor before use
- First Aid Antibiotic solution (injection prep/cleansing): wipe or cleanse the area and discard the wipe after a single use — follow your facility's or prescriber's instructions
- Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc ophthalmic ointment: applied directly to the eye — follow your prescriber's specific directions exactly
🤒Side effects — in detail▾
Side effects are uncommon but can occur, especially with repeated use.
- Skin itching at the application site
- Localized swelling
- Redness or irritation where applied
- Allergic sensitization — developing a skin reaction after repeated exposure
- With the ophthalmic ointment: local eye irritation, itching, eyelid swelling, or redness of the eye (conjunctival erythema)
Rarely, more serious allergic reactions — including anaphylaxis (a severe, whole-body allergic reaction) — have been reported with the ophthalmic ointment. Stop use and get medical help right away if you develop hives, significant swelling, or difficulty breathing.
⚠️Warnings & precautions▾
- For external use only — never swallow these products. If accidentally swallowed, call Poison Control immediately.
- Do not use in the eyes (topical skin products), over large areas of skin, on raw or blistered skin, or for more than 1 week without a doctor's okay.
- Some solution forms are flammable — keep away from fire or open flame and do not use with electrocautery (a heat-based medical tool).
- Ask a doctor before using on deep or puncture wounds, animal bites, or serious burns.
- Stop use and see a doctor if the wound gets worse, doesn't improve, or a rash or allergic reaction develops.
- Keep all forms out of reach of children.
🔀What it interacts with▾
The FDA label for these products does not identify specific drug, food, or supplement interactions for topical use.
- Do not use solution forms with electrocautery procedures — the label specifically warns against this combination
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you have a known allergy to neomycin, polymyxin B, bacitracin, or any other ingredient in the product
- Consult a doctor before use on deep or puncture wounds, animal bites, or serious burns
- Children under 2 years of age: check with a doctor before applying topical forms
- Do not use over large areas of body skin or on raw, blistered surfaces
- Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc ophthalmic ointment is contraindicated (must not be used) in anyone with a hypersensitivity to any of its components
🚑If you take too much▾
If any of these products are swallowed, get medical help or contact a Poison Control Center right away — do not wait for symptoms to appear.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F) .
📄 Written from Neomycin, Polymyxin, and Bacitracin Topical’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Neomycin, Polymyxin, and Bacitracin Topical — the kind of thing our pharmacy team would talk through with you at the counter.
What is this triple antibiotic ointment actually for? ▾
How do I use it correctly? ▾
What side effects should I watch out for? ▾
Can I use it on my child? ▾
Are there wounds I should NOT use this on? ▾
Is the eye ointment version the same as the regular skin ointment? ▾
Is Neomycin, Polymyxin, and Bacitracin Topical available over the counter? ▾
When was Neomycin, Polymyxin, and Bacitracin Topical first available? ▾
Who makes Neomycin, Polymyxin, and Bacitracin Topical? ▾
💬 Answers drafted from Neomycin, Polymyxin, and Bacitracin Topical’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Neomycin, Polymyxin, and Bacitracin Topical comes
Neomycin, Polymyxin, and Bacitracin Topical is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Topical cream, ointment or gel
How this form is used
- Helps prevent infection in minor cuts, scrapes, and burns
- Provides temporary relief of pain and itching from minor burns, cuts, scrapes, and insect bites
- Clean the affected area before applying
- Apply a small amount (about the size of a fingertip) to the area 1 to 3 times daily
- May be covered with a sterile bandage
- Adults and children 2 years and older may use; children under 2 should see a doctor first
Show 27 more strengths Show fewer strengths
Eye ointment
How this form is used
- Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc ophthalmic ointment is used to help prevent bacterial eye infections
- Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc ophthalmic ointment is applied to the eye — follow your prescriber's specific directions
- Do not use this ophthalmic product if you are allergic to any of its ingredients
- Stop use and contact your doctor if eye irritation, swelling, or redness develops
Topical solution
How this form is used
- First Aid Antibiotic solution is used to prepare skin before an injection
- First Aid Antibiotic solution provides antiseptic cleansing of the face, hands, and body without soap and water
- First Aid Antibiotic solution is intended for professional and hospital use
- First Aid Antibiotic solution wipes: wipe the injection site vigorously and discard after use
- First Aid Antibiotic towelette: tear open the packet, unfold, cleanse the desired area, then discard after a single use
- Keep away from fire or flame — this form is flammable
- Do not use in the eyes or with electrocautery procedures
📊 Neomycin, Polymyxin, and Bacitracin Topical across the U.S. market
How Neomycin, Polymyxin, and Bacitracin Topical appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Kit (3) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Neomycin, Polymyxin, and Bacitracin Topical is used
A general measure of how commonly Neomycin, Polymyxin, and Bacitracin Topical is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Neomycin, Polymyxin, and Bacitracin Topical is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Neomycin, Polymyxin, and Bacitracin Topical prescribed? Of the 1,596 medications we measure, Neomycin, Polymyxin, and Bacitracin Topical ranks #605 by Medicaid prescriptions — more than 62% of them.
Utilization by Neomycin, Polymyxin, and Bacitracin Topical product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment
Summed across the 14 of 366 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 204602
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Neomycin, Polymyxin, and Bacitracin Topical, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 14 of 366 listed Neomycin, Polymyxin, and Bacitracin Topical NDCs with Medicaid activity.
🔍 Compare Neomycin, Polymyxin, and Bacitracin Topical products
A representative set of FDA-listed product records for Neomycin, Polymyxin, and Bacitracin Topical — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye ointment | ||||
| 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g | Ophthalmic | Akorn | ANDA | View NDC → |
| NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 10000 [USP'U]/g; BACITRACIN ZINC 400 [USP'U]/g | Ophthalmic | Bausch & Lomb Incorporated | ANDA | View NDC → |
| 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g | Ophthalmic | Bausch & Lomb Incorporated × 2 listings | ANDA | View NDC → |
| 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g | Ophthalmic | Casper Pharma LLC | NDA | View NDC → |
| 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g | Ophthalmic | Henry Schein Inc. | ANDA | View NDC → |
| 400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g | Ophthalmic | Mwi | ANDA | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | A-S Medication Solutions × 3 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | A-S Medication Solutions × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| POLYMYXIN B SULFATE 5000 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g | Topical | A-S Medication Solutions | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Acme United Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 U/g; mg/g; U/g | Topical | Acme United Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Acme United Corporation | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | Acme United Corporation | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Acme United Corporation | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Acme United Corporation | OTC MONOGRAPH DRUG | View NDC → |
| 417.8; 3.5; 5322.8 [IU]/g; mg/g; [IU]/g | Topical | Acme united Corporation | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Advanced First Aid, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Adventure Ready Brands | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Afassco Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Amazon.com Services LLC | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Amazon.com Services LLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | American Sales Company × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | American Sales Company | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | AmerisourceBergen | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | AmerisourceBergen | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Army & Air Force Exchange Service | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Army & Air Force Exchange Service | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Bellegrove Medical Supply, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Bellegrove Medical Supply, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Bi-Mart | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Bi-Mart Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Bi-Mart Corporation | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Bjwc | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Bjwc | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 U/g; mg/g; U/g | Topical | Cardinal Health | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Cardinal Health (Leader) 70000 | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Cardinal Health (Leader) 70000 | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Chain Drug Marketing Association × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Chain Drug Marketing Association | OTC MONOGRAPH DRUG | View NDC → |
| 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g | Topical | Chain Drug Marketing Association Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 500 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 10000 [USP'U]/g; PRAMOXINE HYDROCHLORIDE 10 mg/g | Topical | Chain Drug Marketing Association Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Cintas Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Cintas Corporation | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Cintas Corporation | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Cintas Corporation | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | CMC Group, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | CMC Group, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Cosette Pharmaceuticals, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| POLYMYXIN B SULFATE 5000 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g | Topical | Cosette Pharmaceuticals, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g; BACITRACIN ZINC 400 U/g | Topical | Cosmuses Cosmetics (Ningbo) Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Crane Safety LLC × 5 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; POLYMYXIN B SULFATE 5000 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g | Topical | Crane Safety LLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | CVS Health | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | CVS Pharmacy | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | CVS Pharmacy | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | CVS Pharmacy | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Dealmed Medical Supplies, LLC. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Dealmed Medical Supplies LLC | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Discount Drug Mart, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Dolgencorp, LLC | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Dolgencorp, LLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Dynarex Corporation × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Dynarex Corporation | OTC MONOGRAPH DRUG | View NDC → |
| NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g; BACITRACIN ZINC 400 [USP'U]/g | Topical | Ecolabs Food Safety Specialties, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Ecolabs Food Safety Specialties, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Ecolabs Food Safety Specialties, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 0.0035 g/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Everlit Global Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Ever Ready × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 0.0035; 5000 [USP'U]/g; g/g; [USP'U]/g | Topical | Ever Ready First Aid | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 0.0035 g/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Ever Ready First Aid × 3 listings | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Express Companies, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Ezricare Llc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Ezricare Llc | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | Fourstar Group USA, Inc | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | Fourstar Group Usa, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Fred's, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Fred's, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 0.41 g/100 g; NEOMYCIN SULFATE 0.0035 g/100 g; POLYMYXIN B SULFATE 0.52 g/100 g | Topical | Front Pharmaceutical Plc | OTC MONOGRAPH DRUG | View NDC → |
| 0.41; 0.0035; 0.52 g/100 g; g/100 g; g/100 g | Topical | Front Pharmaceutical Plc | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Front Pharmaceutical PLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Galentic Pharma (India) Private Limited | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B 5000 U/g | Topical | Gentell LLC | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Geri-Care Pharmaceuticals, Corp | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | GFA Production(Xiamen) Co.,Ltd | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | GFA Production (Xiamen) Co., Ltd. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | GFA Production (Xiamen) Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | GFA Production (Xiamen) Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Global Pharma Healthcare Private Limited | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Gobrands, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | H2-Pharma, LLC | OTC MONOGRAPH FINAL | View NDC → |
| POLYMYXIN B SULFATE 0.064 g/g; BACITRACIN ZINC 0.571 g/g; NEOMYCIN SULFATE 0.538 g/g | Topical | Harris Teeter Llc | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | HART Health × 3 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | H E B | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | H E B | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Henry Schein | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 50000 [IU]/g; mg/g; [IU]/g | Topical | Henry Schein | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Henry Schein | OTC MONOGRAPH DRUG | View NDC → |
| POLYMYXIN B SULFATE 50000 [IU]/g; NEOMYCIN SULFATE 5 mg/g; BACITRACIN ZINC 400 [IU]/g | Topical | Henry Schein | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Henry Schein, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Honeywell Safety Products USA, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 35; 5000 [IU]/g; mg/g; [IU]/g | Topical | Hubei Changjian Medical Products Co., Ltd. | OTC MONOGRAPH FINAL | View NDC → |
| 400; 35; 5000 [IU]/g; mg/g; [IU]/g | Topical | Hubei Changjian Medical Products Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 35 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Hubei Changjian Medical Products Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | HyVee Inc | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [CFU]/g; mg/g; [CFU]/g | Topical | J&A Digital Inc. | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [CFU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [CFU]/g | Topical | J&A Digital Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/0.5 g; mg/0.5 g; [IU]/0.5 g | Topical | JHK Inc dba American Safety & First Aid | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/0.5 g; NEOMYCIN SULFATE 3.5 mg/0.5 g; POLYMYXIN B SULFATE 5000 [IU]/0.5 g | Topical | JHK Inc dba American Safety & First Aid | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Johnson & Johnson Consumer Inc. × 4 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Kareway Product, Inc. × 4 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Kenvue Brands LLC × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Kroger Company | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Kroger Company | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | L. Perrigo Company × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | L. Perrigo Company × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Lidl US, LLC | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | Lidl US, LLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Lil' Drug Store Products, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Lil' Drug Store Products, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/1; mg/1; [IU] | Topical | Lil Drug Store Products, Inc | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/1; mg/1; [IU] | Topical | Lil Drug Store Products, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Lil Drug Store Products, Inc | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [IU]/g; mg/g; [IU]/g | Topical | Lil Drug Store Products, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Lil Drug Store Products, Inc | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | M-star (Hubei) Health&Care Products Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Major Pharmaceuticals | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Major Pharmaceuticals | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Major Pharmaceuticals × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Medline Industries, LP × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Medline Industries, LP | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | Meijer Distribution Inc | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Meijer Distribution Inc | OTC MONOGRAPH DRUG | View NDC → |
| 500; 3.5; 10000 U/g; mg/g; U/g | Topical | Melaleuca, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 500 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 10000 U/g | Topical | Melaleuca, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 0.0035; 5000 [USP'U]/g; g/g; [USP'U]/g | Topical | Nantong Health & Beyond Hygienic Products Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 0.0035; 5000 [USP'U]/g; g/g; [USP'U]/g | Topical | Nantong Health & Beyond Hygienic Products Inc. | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 0.0035 g/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Nantong Health & Beyond Hygienic Products Inc. × 9 listings | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | Nantong Health & Beyond Hygienic Products Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| POLYMYXIN B SULFATE 5000 [USP'U]/g; BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g | Topical | Nantong Health & Beyond Hygienic Products Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 U/9.4 g; mg/9.4 g; U/9.4 g | Topical | Natureplex LLC | OTC MONOGRAPH FINAL | View NDC → |
| BACITRACIN ZINC 400 U/9.4 g; NEOMYCIN SULFATE 3.5 mg/9.4 g; POLYMYXIN B SULFATE 5000 U/9.4 g | Topical | Natureplex LLC | OTC MONOGRAPH DRUG | View NDC → |
| 400; 5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | New World Imports, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 400; 5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | New World Imports, Inc | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [USP'U]/g; NEOMYCIN SULFATE 5 mg/g; POLYMYXIN B SULFATE 5000 [USP'U]/g | Topical | New World Imports, Inc × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 [IU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 [IU]/g | Topical | NuCare Pharmaceutical, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g | Topical | NuCare Pharmaceuticals,Inc. | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| POLYMYXIN B SULFATE 5000 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; BACITRACIN ZINC 400 [USP'U]/g | Topical | NuCare Pharmaceuticals,Inc. | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 500 [USP'U]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 10000 [USP'U]/g; PRAMOXINE HYDROCHLORIDE 10 mg/g | Topical | Ol Pharma Tech, Llc | OTC MONOGRAPH DRUG | View NDC → |
| 💊Topical solution | ||||
| 400; 3.5; 5000 U/g; mg/g; U/g | Topical | Hubei Fanjian Medical Product Co.,Ltd | OTC MONOGRAPH DRUG | View NDC → |
| BACITRACIN ZINC 400 U/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 5000 U/g | Topical | Hubei Fanjian Medical Product Co.,Ltd | OTC MONOGRAPH DRUG | View NDC → |
| 💊Kits | ||||
| — | — | GFA Production (Xiamen) Co., Ltd. | OTC MONOGRAPH DRUG | View NDC → |
| — | — | Johnson & Johnson Consumer Inc. | OTC MONOGRAPH DRUG | View NDC → |
| — | — | Kenvue Brands LLC | OTC MONOGRAPH DRUG | View NDC → |
Showing 200 of 391 products — FDA National Drug Code Directory. See every product, package size and price: browse all 391 Neomycin, Polymyxin, and Bacitracin Topical NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Neomycin, Polymyxin, and Bacitracin Topical — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Neomycin, Polymyxin, and Bacitracin Topical in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Neomycin, Polymyxin, and Bacitracin Topical went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one exact multiple-ingredient concept (MIN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). A product with a different ingredient combination belongs on a different page.
RxCUI 477619 3 dose forms · 5 strengths
-
Dose form (SCDF) Ophthalmic Ointment RxCUI 376030In current FDA listingsClinical drug / strength (SCD) bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MGRxCUI 308493 -
Dose form (SCDF) Topical Cream RxCUI 378748In current FDA listingsClinical drug / strength (SCD) bacitracin 400 UNT/ML / neomycin 3.5 MG/ML / polymyxin B 5000 UNT/MLRxCUI 283616 -
Dose form (SCDF) Topical Ointment RxCUI 376031In current FDA listingsClinical drug / strength (SCD) bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 0.5 UNT/MGRxCUI 2714198bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MGRxCUI 204602bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MGRxCUI 1359363
Look up RxCUI 477619 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Neomycin, Polymyxin, and Bacitracin Topical is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Neomycin, Polymyxin, and Bacitracin Topical belongs to the Other antibiotics for topical use class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 172 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Mwi is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.